Risperidone in children with schizophrenia

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 35, Issue 4, 1996, Pages 405-406

  Lykes, William C ^a   Cueva, Jeanette E ^a  

^a ST VINCENT S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; RISPERIDONE;

ARTICLE; CASE REPORT; CHILD; FEMALE; HUMAN; MALE; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; CHILD; FEMALE; HUMANS; MALE; RISPERIDONE; SCHIZOPHRENIA, CHILDHOOD;

EID: 0030113117     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1097/00004583-199604000-00005     Document Type: Letter

References (5)

1. Campbell M, Small AM, Green WH et al. (1984), Behavioral efficacy of haloperidol and lithium carbonate: a comparison in hospitalized aggressive children with conduct disorder. Arch Gen Psychiatry 41:650-656
2. Chouinard G, Jones B, Remington G et al. (1993), A Canadian multicentre placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol 13:25-40
3. Marder SR, Meibach RC (1994), Risperidone in the treatment of schizophrenia. Am J Psychiatry 151:825-835
4. Quintana H, Keshavan M (1995), Case study: risperidone in children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry 34:1292-1296
5. Spencer EK (1994), Haloperidol treatment of hospitalized schizophrenic children. Institute IX: Advanced Topics in Psychopharmacology. Presented at the 41st Annual Meeting of the American Academy of Child and Adolescent Psychiatry